Epicore Biosystems
PrivateLast Round
Grant
Jul 23, 2025
Est. Valuation
$121M
Total Funding Raised
$65.96M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Epicore Biosystems operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in July 2025.
Epicore Biosystems is a digital health company that develops advanced sweat-sensing wearables that provide real-time personalized hydration and health insights.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Sports & Fitness
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epicore Biosystems Comparables
Compare Epicore Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Onalabs Inno-Hub | 88% | |
| Nix Biosensors | 85% | |
| WearOptimo | 81% |
For institutional investors. Book with your work email.
Epicore Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 23, 2025 | ||||
| Series B Extension | May 14, 2025 | ||||
| Series B | Dec 11, 2024 | ||||
| Grant | Jan 23, 2024 | ||||
| Strategic | Jan 17, 2024 | ||||
Series A Extension | Dec 12, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epicore Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Global Brain Corporation | Series B Extension |
| Fenox Venture Capital | Series B Extension |
| Joyance Partners | Series B, Series A, Series B Extension |
| National Heart, Lung, and Blood Institute | Grant |
| Chevron Technology Ventures | Series A |
| Alumni Ventures | Series B, Series A, Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 117% MoM.
- Jan 22, 2026
Added Hivesystems, a cybersecurity SMB, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 7, 2026
On Oct 7th '26, Epicore Biosystems is developing the Chloride Tracker wearable microfluidic platform with MECFA for cystic fibrosis monitoring and management, with Marmara University conducting regional clinical evaluation in Turkey.
- partners_withOct 7, 2026
Epicore Biosystems and MECFA collaborate to develop a wearable microfluidic platform for cystic fibrosis monitoring and management across the Middle East and North Africa.
For institutional investors. Book with your work email.
Epicore Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epicore Biosystems's valuation, stock price, and market status.
Is Epicore Biosystems a public or private company?
Epicore Biosystems is a private company.
What is the current stock price of Epicore Biosystems?
Epicore Biosystems is a private company, so its shares have no public market price. Caplight tracks Epicore Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epicore Biosystems worth (valuation)?
Epicore Biosystems's valuation is estimated at $121.0M based on funding round data.
Can I buy Epicore Biosystems stock?
Epicore Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epicore Biosystems's last funding round?
Epicore Biosystems's most recent funding round was Grant on July 23, 2025.
Who are the main investors in Epicore Biosystems?
Key investors in Epicore Biosystems include Steele Foundation for Hope, Pegasus Tech Ventures.
Will Epicore Biosystems IPO soon?
No public IPO plans have been announced for Epicore Biosystems.
How can I track Epicore Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Epicore Biosystems's shares on secondary markets.